Pfizer on Thursday formally applied for Emergency Use Authorization (EUA) with the Food and Drug Administration for a smaller dose of its COVID-19 vaccine for use in children aged between 5 and 11.
Pfizer on Thursday formally applied for Emergency Use Authorization (EUA) with the Food and Drug Administration for a smaller dose of its COVID-19 vaccine for use in children aged between 5 and 11.
FDA issues EUA for Pfizer vaccine in kids 5 to 11
As soon as this week, 28 million children between ages 5 and 11 may be eligible for the COVID-19 vaccine.